Kiniksa Pharmaceuticals InternationalvsThermo Fisher Scientific

KNSA and TMO stock compared: price, dividend, valuation and results, from SEC filings.

KNSA

Kiniksa Pharmaceuticals International, plc

$94.23

Value $7.0B

-2.18%
KNSA's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

Kiniksa Pharmaceuticals International (KNSA) has a market value of $7.0B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, KNSA moved +133.7% and TMO +19.9%. The P/E is 63.8 for KNSA and 36.3 for TMO. Dividend yield: KNSA none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    KNSA$7.0B

    TMO$257B

    TMO is 37 times KNSA

  • Revenue, 12 months

    KNSA$946M

    TMO$47.4B

    TMO is 50 times KNSA

  • Net income, 12 months

    KNSA$110M

    TMO$7.1B

    TMO is 65 times KNSA

  • Operating margin

    KNSA13.8%

    TMO17.9%

    4.1 points apart

  • ROIC

    KNSA15.9%

    TMO8.2%

    7.7 points apart

  • P/E

    KNSA63.8

    TMO36.3

    KNSA is 1.8 times TMO

  • Dividend yield

    KNSA0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    KNSA+623.2%

    TMO+10.9%

    612.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

KNSA+623.2%

TMO+10.9%

20040060020222023202420252026
Returns by period
PeriodKNSAWith dividendsTMOWith dividends
1 year since November 14, 2025+133.7%Price +133.7%+19.9%Price +19.5%
3 years since November 16, 2023+507.9%+82.5% a yearPrice +507.9%+47.7%+13.9% a yearPrice +46.3%
5 years since November 15, 2021+623.2%+48.5% a yearPrice +623.2%+10.9%+2.1% a yearPrice +9.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

KNSAKiniksa Pharmaceuticals InternationalTMOThermo Fisher Scientific

Valuation

KNSATMO
Valuation
Price$94.23$691.33
Market value$7.0B$257B
Enterprise value (EV)$6.4B$292B
P/E63.836.3
P/E, 5-year median55.032.7
P/B9.94.7
EV/EBIT49.234.5
Free cash flow yield2.8%3.0%

Results and growth

KNSATMO
Results and growth
Revenue, 12 months$946M$47.4B
Net income, 12 months$110M$7.1B
Free cash flow, 12 months$197M$7.6B
Earnings per share, 12 months$1.31$18.96
Revenue growth, year on year60.1%3.9%
Revenue growth a year, past+104.8%over 4 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

KNSATMO
Margins and returns on capital
Gross margin90.2%–
Operating margin13.8%17.9%
Net margin11.6%14.9%
ROIC15.9%8.2%
ROE17.8%13.4%

Balance sheet

KNSATMO
Balance sheet
Cash$569M$6.1B
Total debt$7.9M$41.4B
Net debt / EBITDA-4.33.7
Interest cover–5.5×

Dividends and buybacks

KNSATMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: KNSA or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Kiniksa Pharmaceuticals International or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 36.7 times Kiniksa Pharmaceuticals International ($7.0B), at today's prices.

How did KNSA and TMO stock do over the last 5 years?

Since November 15, 2021, KNSA's price moved +623.2% and TMO's +9.3%. With dividends: KNSA +623.2% (+48.5% a year), TMO +10.9% (+2.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, KNSA or TMO?

The dividend yield at today's price is none for Kiniksa Pharmaceuticals International and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of KNSA and TMO?

At today's price, the P/E is 63.8 for KNSA and 36.3 for TMO. The median of the last five years was 55.0 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, Kiniksa Pharmaceuticals International or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 11.6% for Kiniksa Pharmaceuticals International and 14.9% for Thermo Fisher Scientific, and the operating margin 13.8% and 17.9%. Revenue was $946M and $47.4B.

Which is the better investment, Kiniksa Pharmaceuticals International or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.